Strattera Suicidal Thinking Data Is Of Little Clinical Significance, Lilly Consultants Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Data analysis used as the basis for a public health advisory on Lilly’s Strattera in children and adolescents is unreliable, SUNY Upstate Medical University, Columbia University professors say.